Joel P Joseph
Grant Category: Fulbright-Nehru Doctoral Research Fellowships
Project Title: Developing Biomaterial-based Strategies for T cell-targeted Immunomodulation and 3D Bioprinted T cell Culture Platform for Drug Screening
Field of Study: Bioengineering
Home Institution: Indian Institute of Science, Bengaluru, Karnataka
Host Institution: Case Western Reserve University, Cleveland, OH  
Grant Start Month: August, 2023
Duration of Grant: Nine months

Joel P Joseph
Brief Bio:

Mr. Joel P Joseph is a Ph.D. candidate at the Indian Institute of Science (IISc), Bangalore, Karnataka. His doctoral thesis aims to develop a 3D bioprinted T cell culture platform to screen for novel immunomodulatory compounds and validate them using an in vivo mouse model of an autoimmune disease.

Before starting his Ph.D., Mr. Joseph was Junior Research Fellow at Manipal Institute of Regenerative Medicine, Bengaluru. Here, he investigated the roles of intracellular protein degradation and mitochondrial dynamics in the development of midbrain dopaminergic neurons in mice. Some of his research has been published in peer-reviewed journals and presented at national and international conferences.

He holds a Bachelor of Engineering degree in biotechnology from Sir M Visvesvaraya Institute of Technology, Bengaluru, and a master of technology degree in genetic engineering from SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu.

Mr. Joseph is particularly interested in science communication. His written words have appeared in several science media and education websites based in India. He loves to engage with people from diverse backgrounds and disciplines to exchange ideas on science, society, and culture. When he is not in the lab, he can be found reading, writing, listening to music, or watching stories based on real events.

As a Fulbright-Nehru Doctoral Research fellow, Mr. Joseph is designing nanoparticulate drug delivery systems for immunomodulatory compounds. He is also comparing their efficacies with the free form of drugs using his 3D bioprinted T cell culture platform and validating them using a relevant in vivo mouse model.

www.usief.org.in